TG THERAPEUTICS, INC. (TGTX) Insider Trading & SEC Filings
Last SEC filing
TG THERAPEUTICS, INC. (TGTX) has filed 5 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-15. 5 Form 8-K material event filings were reported by TGTX in the last 90 days. InsiderAlpha tracks every TGTX SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About TG THERAPEUTICS, INC. (TGTX)
TG THERAPEUTICS, INC. trades under the ticker TGTX. InsiderAlpha tracks 17 primary SEC Form 4 filings from 6 reporting insiders for TGTX since 2024, sourced directly from SEC EDGAR.
| Sector | Health Care insider trading |
|---|---|
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
| SEC CIK | 0001001316 |
90-Day SEC Filing Activity
| Form 4 filings (90d) | 5 |
|---|---|
| Form 8-K filings (90d) | 5 |
| Latest Form 4 filing | 2026-06-15 |
Recent TGTX Insider Transactions (Form 4)
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Laurence N. Charney | Director | G - Bona-fide gift | 13.2K | $0.00 | - | SEC | |
| Laurence N. Charney | Director | G - Bona-fide gift | 30.0K | $0.00 | - | SEC | |
| Yann Echelard | Director | S - Open-market sale | 5.0K | $32.57 | $163K | SEC | |
| Michael S. Weiss | CEO | G - Bona-fide gift | 803.7K | $0.00 | - | SEC | |
| Michael S. Weiss | CEO | G - Bona-fide gift | 3.87M | $0.00 | - | SEC | |
| Sagar Lonial | Director | S - Open-market sale | 20.9K | $32.24 | $672K | SEC | |
| Yann Echelard | Director | S - Open-market sale | 10.0K | $36.94 | $369K | SEC | |
| Laurence N. Charney | Director | A - Grant or award | 21.4K | $0.00 | - | SEC | |
| Yann Echelard | Director | A - Grant or award | 14.7K | $0.00 | - | SEC | |
| Kenneth Hoberman | Director | A - Grant or award | 14.7K | $0.00 | - | SEC | |
| Daniel Hume | Director | A - Grant or award | 14.7K | $0.00 | - | SEC | |
| Sagar Lonial | Director | A - Grant or award | 14.7K | $0.00 | - | SEC | |
| Laurence N. Charney | Director | G - Bona-fide gift | 5.0K | $0.00 | - | SEC | |
| Laurence N. Charney | Director | S - Open-market sale | 25.0K | $30.20 | $755K | SEC | |
| Sagar Lonial | Director | S - Open-market sale | 5.0K | $30.44 | $152K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for TG THERAPEUTICS, INC. (TGTX). Updated in real time as new filings are submitted to the SEC.
Most-Active TGTX Insiders - Last 90 Days
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Sagar Lonial | 1 | - |
| Daniel Hume | 1 | - |
| Kenneth Hoberman | 1 | - |
| Laurence N. Charney | 1 | - |
| Yann Echelard | 1 | - |
Recent TGTX Form 8-K Material Events
- - Item 2.02, 9.01 [SEC]
- - Item 5.07 [SEC]
- - Item 8.01, 9.01 [SEC]
- - Item 8.01, 9.01 [SEC]
- - Item 2.02, 9.01 [SEC]
Recent Insider Filings
- - Sagar Lonial (Director)
- - Daniel Hume (Director)
- - Kenneth Hoberman (Director)
- - Yann Echelard (Director)
- - Laurence N. Charney (Director)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in TGTX insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
TGTX Insider Trading - FAQ
- What is the latest insider trade for TGTX?
- TG THERAPEUTICS, INC. (TGTX) had 5 insider filings in the last 90 days, with the most recent on 2026-06-15. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying TGTX stock?
- 0 insider purchases of TGTX were filed in the last 90 days.
- How many insiders are selling TGTX stock?
- 0 insider sales of TGTX were filed in the last 90 days.
- Where can I see TGTX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks TGTX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $TNON Tenon Medical, Inc.
- $TYRA Tyra Biosciences, Inc.
- $UNH UNITEDHEALTH GROUP INC
- $UTHR UNITED THERAPEUTICS Corp
- $VANI Vivani Medical, Inc.
- $VBIO Valion Bio, Inc.
- $VIVS VivoSim Labs, INC.
- $VRDN Viridian Therapeutics, Inc.\DE
- $VTAK Catheter Precision, Inc.
- $VXRT Vaxart, Inc.
Related Companies - Recent Insider Activity
- UNITED THERAPEUTICS Corp (UTHR)
- Liquidia Corp (LQDA)
- PERRIGO Co plc (PRGO)
- BeOne Medicines Ltd. (ONC)
- Processa Pharmaceuticals, Inc. (PCSA)
- Nuvalent, Inc. (NUVL)
- CYTOKINETICS INC (CYTK)
- Elanco Animal Health Inc (ELAN)
- Avalo Therapeutics, Inc. (AVTX)
- NATURES SUNSHINE PRODUCTS INC (NATR)
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live TGTX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.